Cargando…
Type 2 Decompensated Diabetes Mellitus Weaned off Subcutaneous Insulin Therapy by Utilizing a Continuous Glucose Monitoring Device
A case series was conducted on three patients diagnosed with decompensated type 2 diabetes mellitus (T2DM) who had hemoglobin A1c (HbA1c) levels ranging from 9.5% to above 14%. Patients were self-monitoring blood glucose (SMBG) levels four times a day. These patients were seen at the resident contin...
Autores principales: | Manov, AndreyI, Dhillon, Gundip S, Chauhan, Sukhjinder, Asllanaj, Blerina, Uy, Erie S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065865/ https://www.ncbi.nlm.nih.gov/pubmed/37012944 http://dx.doi.org/10.7759/cureus.36970 |
Ejemplares similares
-
Unmasking Type 1 Diabetes in Adults: Insights From Two Cases Revealing Misdiagnosis As Type 2 Diabetes, With Emphasis on Autoimmunity and Continuous Glucose Monitoring
por: Manov, Andre E, et al.
Publicado: (2023) -
The Effectiveness of Continuous Glucose Monitoring Devices in Managing Uncontrolled Diabetes Mellitus: A Retrospective Study
por: Manov, Andre E, et al.
Publicado: (2023) -
Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
por: Chauhan, Sukhjinder, et al.
Publicado: (2023) -
Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022) -
Optic Neuropathy Following Acute Decompensated Hypothyroidism (Myxedema Crisis)
por: McBee, Dylan B, et al.
Publicado: (2023)